Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Up 7.2% – What’s Next?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) rose 7.2% during mid-day trading on Tuesday . The stock traded as high as $15.61 and last traded at $15.61. Approximately 427 shares were traded during trading, a decline of 95% from the average daily volume of 8,371 shares. The stock had previously closed at $14.56.

Analyst Upgrades and Downgrades

Several analysts have commented on TLX shares. William Blair upgraded shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a report on Tuesday, November 19th. UBS Group started coverage on Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They issued a “buy” rating and a $21.00 price objective for the company.

Telix Pharmaceuticals Limited American Depositary Shares Trading Up 7.0 %

The company’s 50 day moving average is $15.61.

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.